MR imaging of late radiation therapy- and chemotherapy-induced injury: A pictorial essay

European Radiology

Volumn 19, Issue 11, 2009, Pages 2716-2727

  Pruzincova L ^a,d   Steno J ^b   Srbecky M ^a   Kalina, P ^b   Rychly B ^a   Boljesikova E ^c   Chorvath M ^c   Novotny M ^b   Procka V ^b   Makaiova I ^b   Belan, V ^a  

^a Derer 's University Hospital Slovakia   (Slovakia)

^b Faculty of Natural Sciences   (Slovakia)

^c St Elisabeth Cancer Institute   (Slovakia)

^d NONE   (Slovakia)

Author keywords

Diffusion weighted imaging; Late therapy induced injury; MR imaging; MR spectroscopy; Perfusion MR imaging; Radiation necrosis

Indexed keywords

ANTINEOPLASTIC AGENT; CHOLINE; CREATINE; N ACETYLASPARTIC ACID;

ARTICLE; BRAIN BLOOD FLOW; CANCER CHEMOTHERAPY; DIFFUSION WEIGHTED IMAGING; HISTOPATHOLOGY; HUMAN; IATROGENIC DISEASE; IMAGE QUALITY; LEUKOENCEPHALOPATHY; MICROANGIOPATHY; NEUROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOPHYSIOLOGY; PERFUSION WEIGHTED IMAGING; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RADIATION INJURY; RADIATION LEUKOENCEPHALOPATHY; RADIATION NECROSIS;

ADULT; ANTINEOPLASTIC AGENTS; BRAIN; BRAIN NEOPLASMS; DIAGNOSTIC IMAGING; DIFFUSION MAGNETIC RESONANCE IMAGING; DRUG THERAPY; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; NECROSIS; RADIATION INJURIES;

EID: 70350173301     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-009-1449-8     Document Type: Article

References (54)

1. Sheline GE, Wara WM, Smith V (1980) Therapeutic irradiation and brain injury. Int J Radiat Oncol Biol Phys 6:1215-1228
2. Ruben JD, Dally M, Bailey M, Smith R, McLean CA et al (2006) Cerebral radiation necrosis: Incidence, outcomes, and risk factors with emphasis on radiation parameters and chemotherapy. Int J Radiation Oncology Biol Phys 65:499-508
3. Johannesen TB, Lien HH, Hole KH, Lote K (2003) Radiological and clinical assessment of long-term brain tumour survivors after radiotherapy. Radiother Oncol 69:169-176
4. Marks JE, Baglan RJ, Prassad SC, Blank WF (1981) Cerebral radionecrosis: incidence and risk in relation to dose, time, fractionation and volume. Int J Radiat Oncol Biol Phys 7:243-252
5. Perry A, Schmidt RE (2006) Cancer therapy-associated CNS neuropathology: an update and review of the literature. Acta Neuropathol 111:197-212
6. Langleben DD, Segall GM (2000) PET in differentiation of recurrent brain tumor from radiation injury. J Nucl Med 41:1861-1867
7. 18F-FDG in acute cerebral radiation injury in the rat: implications for separation of radiation necrosis from tumor recurrence. J Nucl Med 45:1931-1938
8. Sugahara T, Korogi Y, Tomiguchi S, Shigematsu Y, Ikushima I et al (2000) Posttherapeutic intraaxial brain tumor: The value of perfusion-sensitive contrast-enhanced MR imaging for differentiating tumor recurrence from nonneoplastic contrast-enhancing tissue. AJNR Am J Neuroradiol 21:901-909
9. Morris JG, Grattan-Smith P, Panegyres PK, O'Neill P, Soo YS, Langlands AO (1994) Delayed cerebral radiation necrosis. Q J Med 87:119-129
10. Burger PC, Mahley MS Jr, Dudka L, Vogel FS (1979) The morphologic effects of radiation administered therapeutically for intracranial gliomas: A postmortem study of 25 cases. Cancer 44:1256-1272
11. Kumar AJ, Leeds NE, Fuller GN, Tassel PV, Maor MH et al (2000) Malignant gliomas: MR imaging spectrum of radiation therapy- and chemotherapy-induced necrosis of the brain after treatment. Radiology 217:377-384
12. Schultheiss TE, Kun LE, Ang KK, Stephens LC (1995) Radiation response of the central nervous system. Int J Radiat Oncol Biol Phys 31:1093-1112
13. Burger PC, Boyko OB (1991) The pathology of central nervous system radiation injury. In: Gutin PH, Leibel SA, Sheline GE (eds) Radiation injury to the nervous system. Raven, New York, pp 191-208
14. Burger PC, Scheithauer BW (2007) Tumors of the central nervous system. American Registry of Pathology, Washington
15. Ironside JW, Moss TH, Louis DN, Lowe JS, Weller RO (2002) Diagnostic pathology of nervous system tumours. Churchill Livingstone, New York
16. Belka C, Budach W, Kortmann RD, Bamberg M (2001) Radiation induced CNS toxicity-molecular and cellular mechanisms. Br J Cancer 85:1233-1239
17. Lampert PW, Davis RL (1964) Delayed effects of radiation on the human central nervous system: "early" and "late" delayed reactions. Neurology 14:912-917
18. Sugahara T, Korogi Y, Kochi M, Ikushima I, Shigematu Y, Hirai T et al (1999) Usefulness of diffusion-weighted MRI with echoplanar technique in the evaluation of cellularity in gliomas. J Magn Reson Imaging 9:53-60
19. Asao CH, Korogi Y, Kitajima M, Hirai T, Baba Y et al (2005) Diffusion-weighted imaging of radiation-induced brain injury for differentiation from tumor recurrence. AJNR Am J Neuroradiol 26:1455-1460
20. Kono K, Inoue Y, Nakayama K et al (2001) The role of diffusion-weighted imaging in patients with brain tumors. AJNR Am J Neuroradiol 22:1081-1088
21. Hayashida Y, Hirai T, Morishita S, Kitajima M, Murakami R et al (2006) Diffusion-weighted imaging of metastatic brain tumors: Comparison with histologic type and tumor cellularity. AJNR Am J Neuroradiol 27:1419-1425
22. Hein PA, Eskey CJ, Dunn JF, Hug EB (2004) Diffusion-weighted imaging in the follow-up of treated high-grade gliomas: Tumor recurrence versus radiation injury. AJNR Am J Neuroradiol 25:201-209
23. Zeng QS, Li CF, Liu H, Zhen JH, Feng DC (2007) Distinction between recurrent glioma and radiation injury using magnetic resonance spectroscopy in combination with diffusion-weighted imaging. Int J Radiation Oncology Biol Phys 68:151-158
24. Tung GA, Evangelista P, Rogg JM, Duncan JA (2001) Diffusion-weighted MR imaging of rim-enhancing brain masses: Is markedly decreased water diffusion specific for brain abscess? AJR Am J Roentgenol 177:709-712
25. Le Bihan D, Douek P, Argyropoulou M (1993) Diffusion and perfusion magnetic resonance imaging in brain tumors. Top Magn Reson Imaging 5:25-31
26. Moritani T, Ekholm S, Westesson P-L (2004) Diffusion-weighted MR imaging of the brain. Springer Verlag, Berlin Heidelberg New York
27. Ebisu T, Tanaka C, Umeda M et al (1996) Discrimination of brain abscess from necrotic or cystic tumors by echo planar imaging. Magn Reson Imaging 14:1113-1116
28. Fredman DP, Goldman HW, Flanders AE (1997) MR imaging of stereotaxic palidotomy and thalamotomy. AJR Am J Roentgenol 169:894-896
29. Tien RD, Flesberg GJ, Friedman H, Brown M, MacFall J (1994) MR imaging of high-grade cerebral gliomas: Value of diffusion-weighted echoplanar pulse sequences. AJR Am J Roentgenol 162:671-677
30. Hakyemez B, Erdogan C, Yildirim N, Parlak M (2005) Glioblastoma multiforme with atypical diffusion-weighted MR findings. Br J Radiol 78:989-992
31. Aronen HJ, Gazit IE, Louis DN et al (1994) Cerebral blood volume maps of gliomas: Comparison with tumor grade and histologic findings. Radiology 191:41-51
32. Covarrubias DJ, Rosen BR, Lev MH (2004) Dynamic magnetic resonance perfusion imaging of brain tumors. Oncologist 9:528-537
33. Cha S, Knopp EA, Johnson G, Wetzel SG, Litt AW, Zagzag D (2002) Intracranial mass lesions: Dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging. Radiology 223:11-29
34. Cotton F, Hermier M (2006) The advantage of high relaxivity contrast agents in brain perfusion. Eur Radio1 Suppl 16(Suppl 7):M 16-M 26
35. Wong JC, Provenzale JM, Petrella JR (2000) Perfusion MR imaging of brain neoplasms. AJR 174:1147-1157
36. Sugahara T, Korogi Y, Kochi M et al (1998) Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas. AJR Am J Roentgenol 171:1479-1486
37. Aksoy FG, Lev MH (2000) Dynamic contrast- enhanced brain perfusion imaging: Technique and clinical applications. Semin Ultrasound CT MR 21:462-477
38. Sorensen AG, Reimer P (2000) Cerebral MR perfusion imaging. Thieme, Stuttgart
39. Kimura T, Sako K, Tohyama Y, Aizawa S, Yoshida H et al (2003) Diagnosis and treatment of progressive space-occupying radiation necrosis following stereotactic radiosurgery for brain metastasis: Value of proton magnetic resonance spectroscopy. Acta Neurochir (Wien) 145:557-564
40. Ge Y, Law M, Johnson G et al (2005) Dynamic susceptibility contrast perfusion MR imaging of multiple sclerosis lesions: Characterizing hemodynamic impairment and inflammatory activity. AJNR Am J Neuroradiol 26:1539-1547
41. Chong VF-H, Rumpel H, Fan Y-F, Mukherji SK (2001) Temporal lobe changes following radiation therapy: Imaging and proton MR spectroscopic findings. Eur Radiol 11:317-324
42. Edelman RR, Hesselink JR, Zlatkin MB, Crues JV (2006) Clinical magnetic resonance imaging. Saunders, Philadelphia
43. Hollingworth W, Medina LS, Lenkinski RE, Shibata DK, Bernal B et al (2006) A systematic literature review of magnetic resonance spectroscopy for the characterization of brain tumors. AJNR 27:1404-1411
44. 1H MR spectroscopic imaging for increasing diagnostic accuracy. Neuroradiology 47:826-834
45. 201TICI single-photon emission computerized tomography, and gadolinium-enhanced magnetic resonance imaging. J Neurosurg 100:835-841
46. 1H MR spectroscopy in comparison to FDG-PET and IMT-SPECT. Rofo 176:1114-1121
47. Ando K, Ishikura R, Nagami et al (2004) Usefulness of Cho/Cr ratio in proton MR spectroscopy for differentiating residual/recurrent glioma from non-neoplastic lesions. Nippon Igaku Hoshasen Gakkai Zasshi 64:121-126
48. Schlemmer HP, Bachert P, Herfarth K, Zuna I, Debus J et al (2001) Proton MR spectroscopic evaluation of suspicious brain lesions after stereotactic readiotherapy. AJNR Am J Neuroradiol 22:1316-1324
49. Sundgren PC, Mukherji SK (2004) MRS applications in oncology. In: Imaging Economics. http://www.imagingeconomics.com/issues/articles/ 2004-09_06.asp. Accessed 1 Aug 2008
50. Plotkin M, Eisenacher J, Brunh H et al (2004) 123I-IMT SPECT and 1H MR-spectroscopy at 3.0 T in the differential diagnosis of recurrent or residual gliomas: A comparative study. Neurooncol 70:49-58
51. Kimura T, Sako K, Tanaka K, Gotoh T, Tanaka T (2001) In vivo single-voxel proton MR spectroscopy in brain lesions with ring-like enhancement. NMR in Biomed 14:339-349
52. Traber F, Block W, Flacke S et al (2002) 1H MR spectroscopy of brain tumors in the course of radiation therapy: Use of fast spectroscopic imaging and single-voxel spectroscopy for diagnosing recurrence. Rofo 174:33-42
53. Rabinov JD, Lee PL, Barker FG, Louis DN, Harsh GR et al (2002) In vivo 3-T MR spectroscopy in the distinction of recurrent glioma versus radiation effects: Initial experience. Radiology 225:871-879
54. Rock JP, Scarpace L, Hearshen D, Gutierrez J et al (2004) Associations among magnetic resonance spectroscopy, apparent diffusion coefficients, and image guided histopathology with special attention to radiation necrosis. Neurosurgery 54:1111-1119